Farmavita.Net member is developing innovative concept for glogal branding and distribution of remedies and devices for therapy of arthritis.
Company is looking to joint-venture, collaborative development or in-licensing of non-prescrition products, on exclusive basis.
For more details please contact Farmavita.Net.
Farmavita.Net member has developed technology which enables development of oral dosage forms with controlled and site specific release of active pharmaceutical ingredients. Patent pending application.
Company is looking for following types of cooperation:
- Joint-venture and private equity partners
- Collaborative product development
- Consulting or contract research contracts
WE REQUIRE PLANT PROVEN COMMERCIAL TECHNOLOGY TO MANAUFACTURE SPECTINOMYCIN HCL IN INDIA . TECHNOLOGY LICENCENSORS/MANUFACTURING COMPANIES/CONSULTANTS TO SUBMIT THEIR TECHNICAL AND COMMERCIAL PROFILE AND BUSINESS TERMS.
CONTACT; MR.ARVIND GANDHI -GM MKTG ( API AND FINE CHEMICALS) ASENCE PHARMA PVT.LTD.,MUMBAI.
The gradual spread of software automation in drug development may be getting a boost from open source systems. Most e-clinical systems today--from data capture and storage to trial management and operations--are proprietary, despite the excellent work that solutions providers have done to make their products compatible with existing standards-based and de facto standard industry systems.
Our present communication deals with physicochemical parameters, preliminary phytochemical studies and pharmacological impact of Murdannia nudiflora (L) Brenan as analgesic plant which is used in folklore uses of Assam. No reports are available on standardization parameters hence, the present attempt was undertaken to investigate the standardization parameters to establish its authenticity. The study revealed the presence of wide range of phytoconstituents. The determination of these characters will aid future investigators in their Pharmacological analysis of this species.
16-18 October, 2013, Berlin, Germany
4 EVENTS IN ONE:
1. Day 1-2: 3rd Annual - International Pharmaceutical Payers' & HTA Summit: Managing a Limited Budget for Expensive Medicines Whilst Encouraging Innovation
2. Day 3: STREAM 1 - 3rd Annual - AMNOG in Action: Experiences with the German Pharmaceutical Pricing & Reimbursement Reform
3. Day 3: STREAM 2 - 2nd Annual - Market Access for High Value Specialty & Biologic Medicines
4. Day 3: STREAM 3 - Market Access for Vaccines & Infectious Disease Medications
Seven targeted therapies are available for the treatment of RCC but there is still considerable pipeline activity. Currently approved targeted therapies have been unable to produce durable responses in RCC patients and only delay progression. As a consequence, effective treatment options capable of sustaining responses in RCC are still required.
Monitoring news at Farmavita.Net
You can easily monitor all new articles published at Farmavita.Net . Click on the RSS button and bookmark the main RSS feed of Farmavita.Net. RSS button is located in URL field of your browser and also at the lower right side of every Farmavita.Net page